The mission of the FABA-US Chapter is to promote and contribute to the highest quality and safety of biotech/biopharma products used in healthcare. Current healthcare paradigms essentially require the development of disease-modifying therapeutics and certainly technology transformation helps to change the prevailing landscape. Emerging trends in technology like Artificial Intelligence/Machine Learning (AI/ML) in drug discovery, nanomedicine, personalized medicine using CAR T cell therapy and monoclonal antibodies (mAbs) therapeutics, drug repurposing, and development of biosimilars, etc. certainly be reached through the synergy of academia and biotech/biopharma industries. We will liaise with and serve as a non-profit platform to bring together common interests in academic professionals and entrepreneurs who can be involved in biotech/biopharma product development and commercialization.